EMAIL THIS PAGE TO A FRIEND

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Simultaneous determination of amino acid and monoamine neurotransmitters in PC12 cells and rats models of Parkinson's disease using a sensitizing derivatization reagent by UHPLC-MS/MS.


PMID 26021847

Abstract

Multi-analytes simultaneous monitoring of amino acid and monoamine neurotransmitters (NTs) has important scientific significance for their related pathology, physiology and drug screening. In this work, in virtue of a mass spectrometry sensitizing reagent 10-ethyl-acridone-3-sulfonyl chloride (EASC) as derivatization reagent, an Ultra High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS) method was developed and validated for simultaneous determination of six amino acid NTs, two monoamine ones and its one metabolite. The simple and rapid derivatization reaction was innovatively combined with plasma preparation by using EASC acetonitrile solution as protein precipitant. This interesting combination brought the advantages of speediness, simpleness and high-throughput in a cost-effective way. Under the optimized conditions, LODs (0.004-3.80nM) and LOQs (0.014-13.3nM) of EASC derivatized-NTs were calculated and found to be significantly lower than those of direct UHPLC-MS/MS detection about 11.5-275.0 and 14.4-371.4 times, respectively. Moreover, EASC derivatization significantly improved chromatographic resolution and matrix effect when compared with direct UPLC-MS/MS detection method without derivatization. Meanwhile, it also brought acceptable precision (3.0-13.0%, peak area CVs%), accuracy (86.4-112.9%), recovery (88.3-107.8%) and stability (3.8-8.5%, peak area CVs%) results. This method was successfully applied for the antiparkinsonian effect evaluation of levodopa and Ginsenoside Rg1 using PC12 cells and rats models by measuring multiple NTs. This provided a new method for the NTs related studies in the future.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A5835
γ-Aminobutyric acid, BioXtra, ≥99%
C4H9NO2
A2129
γ-Aminobutyric acid, ≥99%
C4H9NO2
A5474
L-Aspartic acid, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C4H7NO4
A9256
L-Aspartic acid, reagent grade, ≥98% (HPLC)
C4H7NO4
A8949
L-Aspartic acid, BioXtra, ≥99% (HPLC)
C4H7NO4
A7219
L-Aspartic acid, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
C4H7NO4
A4534
L-Aspartic acid, BioReagent, suitable for cell culture, suitable for insect cell culture
C4H7NO4
11189
L-Aspartic acid, BioUltra, ≥99.5% (T)
C4H7NO4
W365601
L-Aspartic acid, ≥98%, FG
C4H7NO4
G5667
L-Glutamic acid, PharmaGrade, Ajinomoto, EP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C5H9NO4
W328502
L-Glutamic acid, 99%, FCC
C5H9NO4
G8415
L-Glutamic acid, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-100.5%
C5H9NO4
49449
L-Glutamic acid, BioUltra, ≥99.5% (NT)
C5H9NO4
G1251
L-Glutamic acid, ReagentPlus®, ≥99% (HPLC)
C5H9NO4
S4500
L-Serine, ReagentPlus®, ≥99% (HPLC)
C3H7NO3
RES0908S-A7
L-Serine, PharmaGrade, Ajinomoto, EP, USP, JP, Manufactured under appropriate controls for use in pharma or biopharmaceutical production, suitable for cell culture
C3H7NO3
S4311
L-Serine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
C3H7NO3
84959
L-Serine, BioUltra, ≥99.5% (NT)
C3H7NO3
S1315
L-Serine, PharmaGrade, Ajinomoto, EP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C3H7NO3